Spike Pharmaceuticals Enters Infant Drug Market
Release time:
2020-07-31
Jinder Baby Drug Co., Ltd. Established
Jianfeng Pharmaceutical to Enter Infant Drug Market
News Recently, Zhejiang Jinder Baby Drug Co., Ltd., a Sino-German joint venture controlled by Jianfeng Pharmaceutical, completed registration. Jianfeng Pharmaceutical will use this as a basis to introduce German technology and products and develop the infant drug market.
Zhejiang Jinder Baby Drug Co., Ltd. was jointly funded by Jianfeng Pharmaceutical Co., Ltd., Germany Gefu Pharmaceutical Co., Ltd. and Zhuhai Hengqin Deyunjia International Trade Co., Ltd., with a registered capital of 2000 yuan, of which Jianfeng Pharmaceutical Co., Ltd. contributed 1100 yuan in cash, accounting for 55% of the registered capital ; ge Fu Pharmaceutical invested ,500 yuan, accounting for 25% of the registered capital, with two proprietary technologies of "diazepam suppository" and "paracetamol suppository". De Yunjia contributed 400 yuan in cash, accounting for 20% of the registered capital. The company's registered address is in Jinxi Development Zone, Jinhua City. It will rent the existing factory building of Jianfeng Pharmaceutical Jinxi Pharmaceutical Factory for renovation, and strive to absorb their respective expertise and adopt appropriate advanced technology and scientific management methods. A modern pharmaceutical enterprise focusing on the research and development, production and sales of pharmaceutical preparations for infants and children.
In this cooperation, Gefu Pharmaceuticals has invested in "diazepam suppository" and "acetaminophen suppository" with proprietary technology evaluation. The corresponding products have been listed in Germany, among which diazepam suppository is a therapeutic drug for anti-anxiety, sleep disorder and muscle tension. Acetaminophen is used for fever caused by cold or cold, and is also used to relieve mild to moderate pain. After the establishment of the joint venture company, it will carry out research and development and operation of corresponding products on the basis of these two proprietary technologies.
With the adjustment of my country's population policy and the implementation of the "comprehensive two-child" policy, it is expected that the infant drug market will usher in opportunities for rapid growth. This time, through the establishment of a joint venture company and the introduction of German technology to develop infant drugs, It is an important step taken by Jianfeng Pharmaceutical in response to market demand, and it is also the specific implementation of the company's development strategic plan to expand and strengthen its pharmaceutical business. (this newspaper reporter)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page